UCM uscom limited

0.00%

1.9¢

you would think that product which serves to help combat C19...

First 5 Last

Share
Profile

Follow
Bullrush007

6,121 Posts.

745

26/04/21

20:21

Post #: 52733532
Share

Originally posted by honeysoy: ↑

Agree - as shareholders we always want and hope for more but this result is probably as expected.
Still no great traction on sales and revenue but with no access to US hospitals or clinics Re covid and the Chinese New Year also not helping the results are still reasonably positive even though they are down from the previous record quarter.
the comment that China sales are strong is reassuring.
Shares and current mkt cap are a reflection of all the above and where they are currently at .
This not unexpected result will see a new lot of fed up shareholders run for the exits.
I expect the next 6-12 months we will see the sales improvement that everybody has been waiting an excruciatingly long time for to happen.
would love the ceo and board to wade in and buy a swag of shares on market to show everyone they all feel the same way.
Mkt cap a tiny $25 mill. Ytd cash flow still positive, cash in bank of $2mill , China sales pipeline strong and growing, new bp + product just approved .
I hope my considerable research is correct and in time this will become the 16c stock that becomes the success story that will make me say how lucky I was to find it before it became that success story .

Expand

you would think that product which serves to help combat C19 would get unrestricted access to hospitals and clinics

Sounds like a weak excuse

UCM Price at posting: 15.5¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

'Not possible' to port renewable gas: ACCC takes AGN to court

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $4.759M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	500000	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.9¢	46000	1

View Market Depth

No.	Vol.	Price($)
1	500000	0.014
1	132270	0.012
1	100000	0.010
1	150000	0.008
2	2000000	0.001

Price($)	Vol.	No.
0.019	46000	1
0.020	63256	1
0.021	24866	1
0.022	6549	1
0.055	95083	2

Last trade - 16.21pm 27/06/2025 (20 minute delay)

UCM (ASX) Chart

Day chart unavailable

you would think that product which serves to help combat C19...

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Boss extends June win streak with boosted Alta Mesa extraction rates

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

'Not possible' to port renewable gas: ACCC takes AGN to court

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

you would think that product which serves to help combat C19...

Top Stories

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Boss extends June win streak with boosted Alta Mesa extraction rates

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

'Not possible' to port renewable gas: ACCC takes AGN to court

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News